Assignee
MITOPOWER LLC
US·3 granted patents·5 pending applications·5 citations·filing 2018–2025
Top patents by PatentIndex Score
8 records- 0182US11286274B2Nicotinamide riboside derivatives and their usesMITOPOWER LLC·Filed 2018·Granted Mar 29, 2022·4 cites·7 claims
- 0277US11833167B2Nicotinyl riboside compounds and their usesMITOPOWER LLC·Filed 2019·Granted Dec 5, 2023·1 cites·7 claims
- 0370US12178827B2Nicotinyl riboside compounds and their usesMITOPOWER LLC·Filed 2023·Granted Dec 31, 2024·0 cites·8 claims
- 0466US2025367229A1Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives ThereofMITOPOWER LLC·Filed 2025·Application pending·0 cites
- 0565US2024382512A1Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives ThereofMITOPOWER LLC·Filed 2024·Application pending·0 cites
- 0660US2023255995A1Nicotinyl Riboside Compounds and Their UsesMITOPOWER LLC·Filed 2023·Application pending·0 cites
- 0759US2023014055A1Treatment of Immune-Related Disorders, Kidney Disorders, Liver Disorders, Hemolytic Disorders, and Oxidative Stress-Associated Disorders Using NRH, NARH and Reduced Derivatives ThereofMITOPOWER LLC·Filed 2022·Application pending·0 cites
- 0848US2020397807A1Nicotinyl riboside compounds and their usesMITOPOWER LLC·Filed 2020·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →